Cancer genetics · JAMA · 2010
Paper: chance rarely makes its kidney-cancer gap between gene groups. Its own counts: 1 in 4.
How often chance alone makes a 9% vs 4% gap when risks are equal
The paper says
Kidney cancer hit 4 of 45 patients (9%) with a chemical tag on the KILLIN gene, versus 6 of 155 (4%) with a harmful PTEN mutation. The paper says chance alone would produce a gap this big only about 1 time in 250.
Its own data show
On its own counts, the test the paper says it used gives about 1 time in 4. The paper’s own pass mark is rarer than 1 time in 20. Other common tests give 1 in 10 to 1 in 3. Reaching 1 in 250 would take 8 kidney cancers among the 45, not 4.
Each “1 time in N” says how often chance alone would produce a gap at least this big if both groups truly had the same risk. With only 10 kidney cancers among 200 patients, a gap like this could easily be chance. So the paper’s own counts don’t back its advice of extra kidney checks for the KILLIN group.